Collection of Blood and Blood Products from Patients with Hemochromatosis
The Center for Biologics Evaluation and Research maintains a list of establishments granted approval for a variance to 21CFR640.3(d) and 21CFR640.3(f) in order to collect blood and blood products from patients with hemochromatosis.
Key Resources
- List of Establishments Granted Approval for a Variance to 21CFR640.3(d) and 21CFR640.3(f)
Variances for Collection of Blood and Blood Products from Patients with Hemochromatosis, Information as of January 28, 2016